Kidney Yang Deficiency Syndrome Exacerbates Aβ25-35-Induced Pathological Changes, and Ginsenoside Re Ameliorates Synapse Lesions in Aβ25-35- Injected Rats with Kidney Yang Deficiency Syndrome.

IF 1.8 4区 医学 Q3 CLINICAL NEUROLOGY
Xia Jiang, Lin Chen, Qing Fu, Dan Li Ma, Xue Ting Liu, Xiao Yi Wang
{"title":"Kidney Yang Deficiency Syndrome Exacerbates Aβ<sub>25-35</sub>-Induced Pathological Changes, and Ginsenoside Re Ameliorates Synapse Lesions in Aβ<sub>25-35</sub>- Injected Rats with Kidney Yang Deficiency Syndrome.","authors":"Xia Jiang,&nbsp;Lin Chen,&nbsp;Qing Fu,&nbsp;Dan Li Ma,&nbsp;Xue Ting Liu,&nbsp;Xiao Yi Wang","doi":"10.2174/1567205020666230512094230","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Traditional Chinese medicine (TCM) indicates that Alzheimer's disease (AD) is considered the consequence produced by Kidney Yang Deficiency Syndrome (KDS-Yang), which has similar clinical characteristics to glucocorticoid withdrawal syndrome. Ginsenoside Re (G-Re) has been found to ameliorate the symptoms and pathological impairments of AD. However, it's not clear whether G-Re could protect memory and synapse lesions against kidney deficiency dementia.</p><p><strong>Methods: </strong>Subcutaneous injection of hydrocortisone for 14 days was used to produce KDS-Yang. On the 15th day, Aβ<sub>25-35</sub> peptide was injected into the intracerebroventricular (icv) of KDS-Yang rats. Spine density was analyzed by Golgi staining and the ultrastructural morphology of the synapse was detected using Transmission Electron Microscopy (TEM). Western blot was used to examine the expression of pS396, pS404, Tau-5, tGSK-3β, pS9GSK-3β, Syt, Syn I, GluA1, GluN2B, PSD93, PSD95, β<sub>2</sub>-AR and pS346-b<sub>2</sub>-AR.</p><p><strong>Results: </strong>Hyperphosphorylation of tau in Aβ<sub>25-35</sub>-injected rats with KDS-Yang was stronger than in Aβ<sub>25-35</sub>-injected rats at the sites of Ser396 and Ser404. G-Re improved spatial memory damage detected by Morris water-maze (MWM), enhanced spines density, the thickness of postsynaptic density (PSD) and increased the expression of Syt, Syn I, GluA1, GluN2B, PSD93 and PSD95. Moreover, GRe decreased the hyperphosphorylation of β<sub>2</sub>-AR at serine 346 in Aβ<sub>25-35</sub>-injected rats with KDS-Yang.</p><p><strong>Conclusion: </strong>KDS-Yang might exacerbate AD pathological lesions. Importantly, G-Re is a potential ingredient for protecting against memory and synapse deficits in kidney deficiency dementia.</p>","PeriodicalId":10810,"journal":{"name":"Current Alzheimer research","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Alzheimer research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1567205020666230512094230","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Traditional Chinese medicine (TCM) indicates that Alzheimer's disease (AD) is considered the consequence produced by Kidney Yang Deficiency Syndrome (KDS-Yang), which has similar clinical characteristics to glucocorticoid withdrawal syndrome. Ginsenoside Re (G-Re) has been found to ameliorate the symptoms and pathological impairments of AD. However, it's not clear whether G-Re could protect memory and synapse lesions against kidney deficiency dementia.

Methods: Subcutaneous injection of hydrocortisone for 14 days was used to produce KDS-Yang. On the 15th day, Aβ25-35 peptide was injected into the intracerebroventricular (icv) of KDS-Yang rats. Spine density was analyzed by Golgi staining and the ultrastructural morphology of the synapse was detected using Transmission Electron Microscopy (TEM). Western blot was used to examine the expression of pS396, pS404, Tau-5, tGSK-3β, pS9GSK-3β, Syt, Syn I, GluA1, GluN2B, PSD93, PSD95, β2-AR and pS346-b2-AR.

Results: Hyperphosphorylation of tau in Aβ25-35-injected rats with KDS-Yang was stronger than in Aβ25-35-injected rats at the sites of Ser396 and Ser404. G-Re improved spatial memory damage detected by Morris water-maze (MWM), enhanced spines density, the thickness of postsynaptic density (PSD) and increased the expression of Syt, Syn I, GluA1, GluN2B, PSD93 and PSD95. Moreover, GRe decreased the hyperphosphorylation of β2-AR at serine 346 in Aβ25-35-injected rats with KDS-Yang.

Conclusion: KDS-Yang might exacerbate AD pathological lesions. Importantly, G-Re is a potential ingredient for protecting against memory and synapse deficits in kidney deficiency dementia.

a - β25-35可加重肾阳虚证大鼠的病理改变,人参皂苷可改善a - β25-35注射后大鼠的突触损伤。
背景:中医认为阿尔茨海默病(AD)是由肾阳虚证(KDS-Yang)引起的,其临床特征与糖皮质激素戒断综合征相似。人参皂苷Re (G-Re)已被发现可以改善AD的症状和病理损害。然而,尚不清楚G-Re是否能保护记忆和突触损伤免受肾缺乏性痴呆的侵害。方法:采用氢化可的松皮下注射14 d制备KDS-Yang。第15天,将Aβ25-35肽注射至KDS-Yang大鼠脑室内。采用高尔基染色法分析脊柱密度,透射电镜(TEM)观察突触超微结构形态。Western blot检测pS396、pS404、Tau-5、tGSK-3β、pS9GSK-3β、Syt、Syn I、GluA1、GluN2B、PSD93、PSD95、β2-AR、pS346-b2-AR的表达情况。结果:注射a β25-35的大鼠在Ser396和Ser404位点的过度磷酸化比注射a β25-35的大鼠强。G-Re可改善Morris水迷宫(MWM)检测的空间记忆损伤,增强脊髓密度和突触后密度(PSD)厚度,增加Syt、Syn I、GluA1、GluN2B、PSD93和PSD95的表达。此外,在注射a β25-35的KDS-Yang大鼠中,GRe降低了β2-AR在丝氨酸346处的过度磷酸化。结论:KDS-Yang可能加重AD的病理病变。重要的是,G-Re是防止肾缺乏性痴呆患者的记忆和突触缺陷的潜在成分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Alzheimer research
Current Alzheimer research 医学-神经科学
CiteScore
4.00
自引率
4.80%
发文量
64
审稿时长
4-8 weeks
期刊介绍: Current Alzheimer Research publishes peer-reviewed frontier review, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer’s disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer’s disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer''s disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer’s disease. Current Alzheimer Research provides a comprehensive ''bird''s-eye view'' of the current state of Alzheimer''s research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信